MJN Neuroservices
mjn-neuro is a medical technology company focused on improving the quality of life for people affected by neurological diseases, primarily epilepsy and Alzheimer's. Their flagship product, mjn-SERAS, is a personalized medical device worn as a 3D-printed ear piece that monitors brain electrical activity via EEG and uses AI algorithms to predict and alert users of elevated epilepsy seizure risk in real time. The device connects to an app on Android and iOS phones, allowing users and trusted contacts to receive alerts and track seizure data. The company also develops DREAMER, a digital solution for early detection and monitoring of Alzheimer's disease, featuring a portable device and a web platform for medical decision support. mjn-neuro's products are CE marked and have been developed with clinical validation, positioning the company as an innovator in neurotechnology with a focus on personalized, AI-driven medical devices for neurological conditions.
MJN Neuroservices
mjn-neuro is a medical technology company focused on improving the quality of life for people affected by neurological diseases, primarily epilepsy and Alzheimer's. Their flagship product, mjn-SERAS, is a personalized medical device worn as a 3D-printed ear piece that monitors brain electrical activity via EEG and uses AI algorithms to predict and alert users of elevated epilepsy seizure risk in real time. The device connects to an app on Android and iOS phones, allowing users and trusted contacts to receive alerts and track seizure data. The company also develops DREAMER, a digital solution for early detection and monitoring of Alzheimer's disease, featuring a portable device and a web platform for medical decision support. mjn-neuro's products are CE marked and have been developed with clinical validation, positioning the company as an innovator in neurotechnology with a focus on personalized, AI-driven medical devices for neurological conditions.
TL;DR
Headquarters: Girona, Spain
Flagship product: mjn-SERAS (personalized in-ear EEG for seizure risk alerts)
Regulatory status: CE marked medical device
Technology: 3D‑printed in‑ear EEG + AI algorithms, mobile app connectivity
Funding highlights: Received Horizon 2020 SME Instrument Phase 2 funding and CDTI support
Company Overview
Problem Domain
Epilepsy monitoring and Alzheimer's early detection/monitoring
Founded
2014
Industry
Medical devices / Neurotechnology
Tech Stack
Funding Track Record
Grant funding to support project development and clinical expansion
2095799.00 EUR
Project budget referenced for DREAMER with aid in the form of subsidies
Investor Signal
“Received programmatic and grant funding from European Commission (Horizon 2020 SME Instrument) and CDTI; supported by EIT Health programs”